LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis
Tao Zuo,1,* Ping Jiang,2,* Jun Fu,1 Yongjian Zhang1 1Department of Thoracic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Department of Ophthalmology, Zhongnan Hospital of Wuhan Unive...
Main Authors: | Zuo T, Jiang P, Fu J, Zhang Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/lncrna-afap1-as1-induces-gefitinib-resistance-of-lung-adenocarcinoma-t-peer-reviewed-fulltext-article-TCRM |
Similar Items
-
The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma
by: Ma Lina, et al.
Published: (2023-04-01) -
Efficacy of Gefitinib for Young Patients with Unknown EGFR Gene Mutation
in Advanced Lung Adenocarcinoma
by: Yutao LIU, et al.
Published: (2014-05-01) -
Clinic outcome of gefitinib in sixty-nine elderly patients with lung adenocarcinoma
by: Datong CHU, et al.
Published: (2008-02-01) -
Effect of aerobic exercise on acquired gefitinib resistance in lung adenocarcinoma
by: Hong Yang, et al.
Published: (2021-11-01) -
LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p
by: Dang Y, et al.
Published: (2021-06-01)